Company
Board Member
2024-08-15–present
Matthew Pauls
Board Member
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Matthew Pauls
The company reported in an 8-K filed May 18, 2026 that Matthew Pauls resigned as member of the Company's board of directors, effective May 18, 2026. The company reported in an 8-K filed August 15, 2024 that Matthew Pauls was appointed Lead Independent Director. The company reported in an 8-K filed August 16, 2023 that Matthew Pauls was appointed Class II director, effective August 15, 2023.
“each of Anish Bhatnagar, M.D., Mark Hahn, Matthew Pauls, Birgitte Volck, Andrew Sinclair and Dawn Bir resigned from his or her respective positions as a member of the Company's board of directors and all committees thereof effective as of the Effective Time.”
“Following Dr. Mario's resignation, the Board appointed current director Matthew Pauls to the position of Lead Independent Director of the Board and current director Andrew Sinclair to the position of Chairman of the Compensation Committee of the Board to fill the vacancy created by Dr. Mario's retirement.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Organization not stated
SEC 8-K
Current2024-08-15–present
-
Organization not stated
Board Member
SEC 8-K
Current2024-08-15–present
-
Organization not stated
Board Member
Proxy statement
Start not stated–2026-05-18
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Executive change Resigned: member of the Company's board of directors
-
Executive change Appointed: Lead Independent Director
-
Executive change Appointed: Class II director